Michael S. Cuffe, the EVP and Chief Clinical Officer of $HCA, sold 3,836 shares of the company on 09-08-2025 for an estimated $1,606,670. We received data on the trade from a recent SEC filing. This was a sale of approximately 10.9% of their shares of this class of stock. Following this trade, they now own 31,502 shares of this class of $HCA stock.
$HCA Insider Trading Activity
$HCA insiders have traded $HCA stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $HCA stock by insiders over the last 6 months:
- JON M FOSTER (EVP and COO) sold 15,698 shares for an estimated $5,797,660
- MICHAEL S. CUFFE (EVP and Chief Clinical Officer) sold 3,836 shares for an estimated $1,606,670
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$HCA Hedge Fund Activity
We have seen 561 institutional investors add shares of $HCA stock to their portfolio, and 663 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- GAMMA INVESTING LLC removed 1,700,665 shares (-99.8%) from their portfolio in Q2 2025, for an estimated $651,524,761
- CAPITAL WORLD INVESTORS added 1,399,488 shares (+41.4%) to their portfolio in Q2 2025, for an estimated $536,143,852
- PACER ADVISORS, INC. removed 1,336,274 shares (-98.9%) from their portfolio in Q2 2025, for an estimated $511,926,569
- WELLINGTON MANAGEMENT GROUP LLP removed 1,132,118 shares (-21.6%) from their portfolio in Q2 2025, for an estimated $433,714,405
- PRICE T ROWE ASSOCIATES INC /MD/ removed 1,033,134 shares (-43.1%) from their portfolio in Q2 2025, for an estimated $395,793,635
- BANK OF AMERICA CORP /DE/ removed 985,814 shares (-30.0%) from their portfolio in Q2 2025, for an estimated $377,665,343
- MFN PARTNERS MANAGEMENT, LP removed 973,898 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $373,100,323
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$HCA Congressional Stock Trading
Members of Congress have traded $HCA stock 3 times in the past 6 months. Of those trades, 2 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $HCA stock by members of Congress over the last 6 months:
- REPRESENTATIVE JARED MOSKOWITZ has traded it 2 times. They made 2 purchases worth up to $30,000 on 05/15 and 0 sales.
- REPRESENTATIVE JULIE JOHNSON sold up to $15,000 on 04/07.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$HCA Analyst Ratings
Wall Street analysts have issued reports on $HCA in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Cantor Fitzgerald issued a "Overweight" rating on 08/26/2025
- Barclays issued a "Overweight" rating on 07/28/2025
- RBC Capital issued a "Outperform" rating on 07/28/2025
- Truist Securities issued a "Buy" rating on 07/16/2025
- B of A Securities issued a "Buy" rating on 05/13/2025
To track analyst ratings and price targets for $HCA, check out Quiver Quantitative's $HCA forecast page.
$HCA Price Targets
Multiple analysts have issued price targets for $HCA recently. We have seen 9 analysts offer price targets for $HCA in the last 6 months, with a median target of $401.0.
Here are some recent targets:
- Sarah James from Cantor Fitzgerald set a target price of $444.0 on 08/26/2025
- Michael Ha from Baird set a target price of $423.0 on 08/14/2025
- Stephen Baxter from Wells Fargo set a target price of $375.0 on 08/14/2025
- Benjamin Rossi from JP Morgan set a target price of $370.0 on 08/04/2025
- Andrew Mok from Barclays set a target price of $390.0 on 07/28/2025
- Ben Hendrix from RBC Capital set a target price of $401.0 on 07/28/2025
- Craig Hettenbach from Morgan Stanley set a target price of $400.0 on 07/28/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
